nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—ESR1—liver cancer	0.774	1	CbGaD
Etonogestrel—Quinestrol—ESR1—liver cancer	0.00134	0.203	CrCbGaD
Etonogestrel—Mestranol—ESR1—liver cancer	0.00101	0.154	CrCbGaD
Etonogestrel—Desogestrel—ESR1—liver cancer	0.001	0.152	CrCbGaD
Etonogestrel—Norgestimate—ESR1—liver cancer	0.000937	0.142	CrCbGaD
Etonogestrel—Urinary tract disorder—Sorafenib—liver cancer	0.000761	0.00609	CcSEcCtD
Etonogestrel—Connective tissue disorder—Sorafenib—liver cancer	0.000757	0.00606	CcSEcCtD
Etonogestrel—Urethral disorder—Sorafenib—liver cancer	0.000755	0.00604	CcSEcCtD
Etonogestrel—Otitis media—Epirubicin—liver cancer	0.000728	0.00583	CcSEcCtD
Etonogestrel—Abscess—Epirubicin—liver cancer	0.000717	0.00573	CcSEcCtD
Etonogestrel—Angiopathy—Sorafenib—liver cancer	0.000699	0.00559	CcSEcCtD
Etonogestrel—Immune system disorder—Sorafenib—liver cancer	0.000696	0.00557	CcSEcCtD
Etonogestrel—Injection site pain—Epirubicin—liver cancer	0.000695	0.00556	CcSEcCtD
Etonogestrel—Alopecia—Sorafenib—liver cancer	0.000681	0.00545	CcSEcCtD
Etonogestrel—Mental disorder—Sorafenib—liver cancer	0.000675	0.0054	CcSEcCtD
Etonogestrel—Otitis media—Doxorubicin—liver cancer	0.000674	0.00539	CcSEcCtD
Etonogestrel—Erythema—Sorafenib—liver cancer	0.000671	0.00537	CcSEcCtD
Etonogestrel—Malnutrition—Sorafenib—liver cancer	0.000671	0.00537	CcSEcCtD
Etonogestrel—Abscess—Doxorubicin—liver cancer	0.000663	0.0053	CcSEcCtD
Etonogestrel—Breast pain—Epirubicin—liver cancer	0.00065	0.0052	CcSEcCtD
Etonogestrel—Amenorrhoea—Epirubicin—liver cancer	0.000645	0.00516	CcSEcCtD
Etonogestrel—Muscle spasms—Sorafenib—liver cancer	0.000645	0.00516	CcSEcCtD
Etonogestrel—Injection site pain—Doxorubicin—liver cancer	0.000643	0.00514	CcSEcCtD
Etonogestrel—Herpes simplex—Epirubicin—liver cancer	0.000615	0.00492	CcSEcCtD
Etonogestrel—Angioedema—Sorafenib—liver cancer	0.000613	0.0049	CcSEcCtD
Etonogestrel—Breast pain—Doxorubicin—liver cancer	0.000601	0.00481	CcSEcCtD
Etonogestrel—Amenorrhoea—Doxorubicin—liver cancer	0.000597	0.00478	CcSEcCtD
Etonogestrel—Bone pain—Epirubicin—liver cancer	0.000592	0.00474	CcSEcCtD
Etonogestrel—Cough—Sorafenib—liver cancer	0.000585	0.00468	CcSEcCtD
Etonogestrel—Hypertension—Sorafenib—liver cancer	0.000579	0.00463	CcSEcCtD
Etonogestrel—Musculoskeletal pain—Epirubicin—liver cancer	0.000574	0.00459	CcSEcCtD
Etonogestrel—Levonorgestrel—ESR1—liver cancer	0.000574	0.087	CrCbGaD
Etonogestrel—Myalgia—Sorafenib—liver cancer	0.000571	0.00457	CcSEcCtD
Etonogestrel—Arthralgia—Sorafenib—liver cancer	0.000571	0.00457	CcSEcCtD
Etonogestrel—Herpes simplex—Doxorubicin—liver cancer	0.000569	0.00455	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000567	0.00454	CcSEcCtD
Etonogestrel—Vaginal inflammation—Epirubicin—liver cancer	0.000567	0.00454	CcSEcCtD
Etonogestrel—Hepatocellular injury—Epirubicin—liver cancer	0.000567	0.00454	CcSEcCtD
Etonogestrel—Injection site reaction—Epirubicin—liver cancer	0.000564	0.00451	CcSEcCtD
Etonogestrel—Cystitis noninfective—Epirubicin—liver cancer	0.000554	0.00443	CcSEcCtD
Etonogestrel—Influenza like illness—Epirubicin—liver cancer	0.000551	0.00441	CcSEcCtD
Etonogestrel—Bone pain—Doxorubicin—liver cancer	0.000548	0.00438	CcSEcCtD
Etonogestrel—Cystitis—Epirubicin—liver cancer	0.000548	0.00438	CcSEcCtD
Etonogestrel—Anaphylactic shock—Sorafenib—liver cancer	0.000547	0.00438	CcSEcCtD
Etonogestrel—Infection—Sorafenib—liver cancer	0.000544	0.00435	CcSEcCtD
Etonogestrel—Fluid retention—Epirubicin—liver cancer	0.000538	0.00431	CcSEcCtD
Etonogestrel—Nervous system disorder—Sorafenib—liver cancer	0.000537	0.00429	CcSEcCtD
Etonogestrel—Vaginal infection—Epirubicin—liver cancer	0.000535	0.00428	CcSEcCtD
Etonogestrel—Skin disorder—Sorafenib—liver cancer	0.000532	0.00425	CcSEcCtD
Etonogestrel—Musculoskeletal pain—Doxorubicin—liver cancer	0.000531	0.00425	CcSEcCtD
Etonogestrel—Vaginal inflammation—Doxorubicin—liver cancer	0.000525	0.0042	CcSEcCtD
Etonogestrel—Hepatocellular injury—Doxorubicin—liver cancer	0.000525	0.0042	CcSEcCtD
Etonogestrel—Danazol—ESR1—liver cancer	0.000523	0.0792	CrCbGaD
Etonogestrel—Anorexia—Sorafenib—liver cancer	0.000522	0.00417	CcSEcCtD
Etonogestrel—Injection site reaction—Doxorubicin—liver cancer	0.000522	0.00417	CcSEcCtD
Etonogestrel—Bladder pain—Epirubicin—liver cancer	0.000513	0.0041	CcSEcCtD
Etonogestrel—Neoplasm—Epirubicin—liver cancer	0.000513	0.0041	CcSEcCtD
Etonogestrel—Cystitis noninfective—Doxorubicin—liver cancer	0.000513	0.0041	CcSEcCtD
Etonogestrel—Influenza like illness—Doxorubicin—liver cancer	0.00051	0.00408	CcSEcCtD
Etonogestrel—Cystitis—Doxorubicin—liver cancer	0.000507	0.00405	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000499	0.00399	CcSEcCtD
Etonogestrel—Fluid retention—Doxorubicin—liver cancer	0.000498	0.00398	CcSEcCtD
Etonogestrel—Vaginal infection—Doxorubicin—liver cancer	0.000495	0.00396	CcSEcCtD
Etonogestrel—Abnormal vision—Epirubicin—liver cancer	0.000495	0.00396	CcSEcCtD
Etonogestrel—Ethinyl Estradiol—ESR1—liver cancer	0.000484	0.0733	CrCbGaD
Etonogestrel—Dyspepsia—Sorafenib—liver cancer	0.000482	0.00385	CcSEcCtD
Etonogestrel—Decreased appetite—Sorafenib—liver cancer	0.000476	0.00381	CcSEcCtD
Etonogestrel—Bladder pain—Doxorubicin—liver cancer	0.000474	0.00379	CcSEcCtD
Etonogestrel—Neoplasm—Doxorubicin—liver cancer	0.000474	0.00379	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Sorafenib—liver cancer	0.000473	0.00378	CcSEcCtD
Etonogestrel—Fatigue—Sorafenib—liver cancer	0.000472	0.00378	CcSEcCtD
Etonogestrel—Pain—Sorafenib—liver cancer	0.000468	0.00374	CcSEcCtD
Etonogestrel—Constipation—Sorafenib—liver cancer	0.000468	0.00374	CcSEcCtD
Etonogestrel—Eczema—Epirubicin—liver cancer	0.000458	0.00366	CcSEcCtD
Etonogestrel—Abnormal vision—Doxorubicin—liver cancer	0.000458	0.00366	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Sorafenib—liver cancer	0.000448	0.00358	CcSEcCtD
Etonogestrel—Hot flush—Epirubicin—liver cancer	0.00044	0.00352	CcSEcCtD
Etonogestrel—Increased appetite—Epirubicin—liver cancer	0.000438	0.0035	CcSEcCtD
Etonogestrel—Menopausal symptoms—Epirubicin—liver cancer	0.000436	0.00349	CcSEcCtD
Etonogestrel—Urticaria—Sorafenib—liver cancer	0.000435	0.00348	CcSEcCtD
Etonogestrel—Body temperature increased—Sorafenib—liver cancer	0.000433	0.00346	CcSEcCtD
Etonogestrel—Abdominal pain—Sorafenib—liver cancer	0.000433	0.00346	CcSEcCtD
Etonogestrel—Eczema—Doxorubicin—liver cancer	0.000424	0.00339	CcSEcCtD
Etonogestrel—Pain in extremity—Epirubicin—liver cancer	0.000412	0.00329	CcSEcCtD
Etonogestrel—Hot flush—Doxorubicin—liver cancer	0.000407	0.00326	CcSEcCtD
Etonogestrel—Increased appetite—Doxorubicin—liver cancer	0.000405	0.00324	CcSEcCtD
Etonogestrel—Migraine—Epirubicin—liver cancer	0.000405	0.00324	CcSEcCtD
Etonogestrel—Affect lability—Epirubicin—liver cancer	0.000405	0.00324	CcSEcCtD
Etonogestrel—Menopausal symptoms—Doxorubicin—liver cancer	0.000404	0.00323	CcSEcCtD
Etonogestrel—Hypersensitivity—Sorafenib—liver cancer	0.000403	0.00323	CcSEcCtD
Etonogestrel—Asthenia—Sorafenib—liver cancer	0.000393	0.00314	CcSEcCtD
Etonogestrel—Mood swings—Epirubicin—liver cancer	0.00039	0.00312	CcSEcCtD
Etonogestrel—Pruritus—Sorafenib—liver cancer	0.000387	0.0031	CcSEcCtD
Etonogestrel—Pain in extremity—Doxorubicin—liver cancer	0.000381	0.00305	CcSEcCtD
Etonogestrel—Migraine—Doxorubicin—liver cancer	0.000375	0.003	CcSEcCtD
Etonogestrel—Affect lability—Doxorubicin—liver cancer	0.000375	0.003	CcSEcCtD
Etonogestrel—Diarrhoea—Sorafenib—liver cancer	0.000375	0.003	CcSEcCtD
Etonogestrel—Breast disorder—Epirubicin—liver cancer	0.000372	0.00298	CcSEcCtD
Etonogestrel—Gastritis—Epirubicin—liver cancer	0.000364	0.00291	CcSEcCtD
Etonogestrel—Dizziness—Sorafenib—liver cancer	0.000362	0.0029	CcSEcCtD
Etonogestrel—Mood swings—Doxorubicin—liver cancer	0.000361	0.00289	CcSEcCtD
Etonogestrel—Abdominal distension—Epirubicin—liver cancer	0.000358	0.00286	CcSEcCtD
Etonogestrel—Asthma—Epirubicin—liver cancer	0.000356	0.00285	CcSEcCtD
Etonogestrel—Vomiting—Sorafenib—liver cancer	0.000348	0.00278	CcSEcCtD
Etonogestrel—Rash—Sorafenib—liver cancer	0.000345	0.00276	CcSEcCtD
Etonogestrel—Dermatitis—Sorafenib—liver cancer	0.000345	0.00276	CcSEcCtD
Etonogestrel—Breast disorder—Doxorubicin—liver cancer	0.000344	0.00275	CcSEcCtD
Etonogestrel—Headache—Sorafenib—liver cancer	0.000343	0.00274	CcSEcCtD
Etonogestrel—Bronchitis—Epirubicin—liver cancer	0.000342	0.00274	CcSEcCtD
Etonogestrel—Gastritis—Doxorubicin—liver cancer	0.000337	0.0027	CcSEcCtD
Etonogestrel—Dysuria—Epirubicin—liver cancer	0.000333	0.00266	CcSEcCtD
Etonogestrel—Abdominal distension—Doxorubicin—liver cancer	0.000331	0.00265	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Epirubicin—liver cancer	0.000331	0.00264	CcSEcCtD
Etonogestrel—Asthma—Doxorubicin—liver cancer	0.000329	0.00263	CcSEcCtD
Etonogestrel—Pollakiuria—Epirubicin—liver cancer	0.000329	0.00263	CcSEcCtD
Etonogestrel—Nausea—Sorafenib—liver cancer	0.000325	0.0026	CcSEcCtD
Etonogestrel—Weight increased—Epirubicin—liver cancer	0.000324	0.00259	CcSEcCtD
Etonogestrel—Weight decreased—Epirubicin—liver cancer	0.000322	0.00257	CcSEcCtD
Etonogestrel—Infestation—Epirubicin—liver cancer	0.000317	0.00254	CcSEcCtD
Etonogestrel—Infestation NOS—Epirubicin—liver cancer	0.000317	0.00254	CcSEcCtD
Etonogestrel—Bronchitis—Doxorubicin—liver cancer	0.000317	0.00253	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Epirubicin—liver cancer	0.000311	0.00249	CcSEcCtD
Etonogestrel—Urinary tract infection—Epirubicin—liver cancer	0.000308	0.00247	CcSEcCtD
Etonogestrel—Dysuria—Doxorubicin—liver cancer	0.000308	0.00246	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000306	0.00245	CcSEcCtD
Etonogestrel—Pollakiuria—Doxorubicin—liver cancer	0.000304	0.00243	CcSEcCtD
Etonogestrel—Weight increased—Doxorubicin—liver cancer	0.0003	0.0024	CcSEcCtD
Etonogestrel—Weight decreased—Doxorubicin—liver cancer	0.000298	0.00238	CcSEcCtD
Etonogestrel—Sinusitis—Epirubicin—liver cancer	0.000298	0.00238	CcSEcCtD
Etonogestrel—Infestation—Doxorubicin—liver cancer	0.000294	0.00235	CcSEcCtD
Etonogestrel—Infestation NOS—Doxorubicin—liver cancer	0.000294	0.00235	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Doxorubicin—liver cancer	0.000288	0.0023	CcSEcCtD
Etonogestrel—Haemoglobin—Epirubicin—liver cancer	0.000286	0.00229	CcSEcCtD
Etonogestrel—Rhinitis—Epirubicin—liver cancer	0.000286	0.00228	CcSEcCtD
Etonogestrel—Urinary tract infection—Doxorubicin—liver cancer	0.000285	0.00228	CcSEcCtD
Etonogestrel—Haemorrhage—Epirubicin—liver cancer	0.000285	0.00228	CcSEcCtD
Etonogestrel—Hypoaesthesia—Epirubicin—liver cancer	0.000283	0.00227	CcSEcCtD
Etonogestrel—Pharyngitis—Epirubicin—liver cancer	0.000283	0.00226	CcSEcCtD
Etonogestrel—Urinary tract disorder—Epirubicin—liver cancer	0.000281	0.00225	CcSEcCtD
Etonogestrel—Connective tissue disorder—Epirubicin—liver cancer	0.00028	0.00224	CcSEcCtD
Etonogestrel—Urethral disorder—Epirubicin—liver cancer	0.000279	0.00223	CcSEcCtD
Etonogestrel—Sinusitis—Doxorubicin—liver cancer	0.000275	0.0022	CcSEcCtD
Etonogestrel—Visual impairment—Epirubicin—liver cancer	0.000274	0.0022	CcSEcCtD
Etonogestrel—Eye disorder—Epirubicin—liver cancer	0.000266	0.00213	CcSEcCtD
Etonogestrel—Haemoglobin—Doxorubicin—liver cancer	0.000265	0.00212	CcSEcCtD
Etonogestrel—Rhinitis—Doxorubicin—liver cancer	0.000264	0.00211	CcSEcCtD
Etonogestrel—Haemorrhage—Doxorubicin—liver cancer	0.000264	0.00211	CcSEcCtD
Etonogestrel—Hypoaesthesia—Doxorubicin—liver cancer	0.000262	0.0021	CcSEcCtD
Etonogestrel—Pharyngitis—Doxorubicin—liver cancer	0.000262	0.00209	CcSEcCtD
Etonogestrel—Urinary tract disorder—Doxorubicin—liver cancer	0.00026	0.00208	CcSEcCtD
Etonogestrel—Connective tissue disorder—Doxorubicin—liver cancer	0.000259	0.00207	CcSEcCtD
Etonogestrel—Angiopathy—Epirubicin—liver cancer	0.000258	0.00207	CcSEcCtD
Etonogestrel—Urethral disorder—Doxorubicin—liver cancer	0.000258	0.00207	CcSEcCtD
Etonogestrel—Immune system disorder—Epirubicin—liver cancer	0.000257	0.00206	CcSEcCtD
Etonogestrel—Visual impairment—Doxorubicin—liver cancer	0.000254	0.00203	CcSEcCtD
Etonogestrel—Alopecia—Epirubicin—liver cancer	0.000252	0.00201	CcSEcCtD
Etonogestrel—Mental disorder—Epirubicin—liver cancer	0.000249	0.002	CcSEcCtD
Etonogestrel—Erythema—Epirubicin—liver cancer	0.000248	0.00198	CcSEcCtD
Etonogestrel—Malnutrition—Epirubicin—liver cancer	0.000248	0.00198	CcSEcCtD
Etonogestrel—Eye disorder—Doxorubicin—liver cancer	0.000246	0.00197	CcSEcCtD
Etonogestrel—Flatulence—Epirubicin—liver cancer	0.000244	0.00195	CcSEcCtD
Etonogestrel—Tension—Epirubicin—liver cancer	0.000243	0.00195	CcSEcCtD
Etonogestrel—Nervousness—Epirubicin—liver cancer	0.000241	0.00193	CcSEcCtD
Etonogestrel—Back pain—Epirubicin—liver cancer	0.00024	0.00192	CcSEcCtD
Etonogestrel—Angiopathy—Doxorubicin—liver cancer	0.000239	0.00191	CcSEcCtD
Etonogestrel—Muscle spasms—Epirubicin—liver cancer	0.000238	0.00191	CcSEcCtD
Etonogestrel—Immune system disorder—Doxorubicin—liver cancer	0.000238	0.0019	CcSEcCtD
Etonogestrel—Alopecia—Doxorubicin—liver cancer	0.000233	0.00186	CcSEcCtD
Etonogestrel—Mental disorder—Doxorubicin—liver cancer	0.000231	0.00185	CcSEcCtD
Etonogestrel—Ill-defined disorder—Epirubicin—liver cancer	0.00023	0.00184	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—liver cancer	0.000229	0.00183	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—liver cancer	0.000229	0.00183	CcSEcCtD
Etonogestrel—Flatulence—Doxorubicin—liver cancer	0.000226	0.00181	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—liver cancer	0.000225	0.0018	CcSEcCtD
Etonogestrel—Malaise—Epirubicin—liver cancer	0.000224	0.00179	CcSEcCtD
Etonogestrel—Nervousness—Doxorubicin—liver cancer	0.000223	0.00178	CcSEcCtD
Etonogestrel—Back pain—Doxorubicin—liver cancer	0.000222	0.00177	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—liver cancer	0.000221	0.00176	CcSEcCtD
Etonogestrel—Cough—Epirubicin—liver cancer	0.000216	0.00173	CcSEcCtD
Etonogestrel—Convulsion—Epirubicin—liver cancer	0.000215	0.00172	CcSEcCtD
Etonogestrel—Hypertension—Epirubicin—liver cancer	0.000214	0.00171	CcSEcCtD
Etonogestrel—Ill-defined disorder—Doxorubicin—liver cancer	0.000213	0.0017	CcSEcCtD
Etonogestrel—Myalgia—Epirubicin—liver cancer	0.000211	0.00169	CcSEcCtD
Etonogestrel—Arthralgia—Epirubicin—liver cancer	0.000211	0.00169	CcSEcCtD
Etonogestrel—Anxiety—Epirubicin—liver cancer	0.00021	0.00168	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00021	0.00168	CcSEcCtD
Etonogestrel—Discomfort—Epirubicin—liver cancer	0.000209	0.00167	CcSEcCtD
Etonogestrel—Norethindrone—ALB—liver cancer	0.000207	0.0314	CrCbGaD
Etonogestrel—Malaise—Doxorubicin—liver cancer	0.000207	0.00165	CcSEcCtD
Etonogestrel—Testosterone—CYP1A1—liver cancer	0.000205	0.0311	CrCbGaD
Etonogestrel—Anaphylactic shock—Epirubicin—liver cancer	0.000202	0.00162	CcSEcCtD
Etonogestrel—Oedema—Epirubicin—liver cancer	0.000202	0.00162	CcSEcCtD
Etonogestrel—Infection—Epirubicin—liver cancer	0.000201	0.00161	CcSEcCtD
Etonogestrel—Cough—Doxorubicin—liver cancer	0.0002	0.0016	CcSEcCtD
Etonogestrel—Convulsion—Doxorubicin—liver cancer	0.000199	0.00159	CcSEcCtD
Etonogestrel—Nervous system disorder—Epirubicin—liver cancer	0.000198	0.00159	CcSEcCtD
Etonogestrel—Hypertension—Doxorubicin—liver cancer	0.000198	0.00158	CcSEcCtD
Etonogestrel—Methyltestosterone—ALB—liver cancer	0.000197	0.0298	CrCbGaD
Etonogestrel—Skin disorder—Epirubicin—liver cancer	0.000197	0.00157	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—liver cancer	0.000195	0.00156	CcSEcCtD
Etonogestrel—Arthralgia—Doxorubicin—liver cancer	0.000195	0.00156	CcSEcCtD
Etonogestrel—Anxiety—Doxorubicin—liver cancer	0.000195	0.00156	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000194	0.00155	CcSEcCtD
Etonogestrel—Discomfort—Doxorubicin—liver cancer	0.000193	0.00154	CcSEcCtD
Etonogestrel—Anorexia—Epirubicin—liver cancer	0.000193	0.00154	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—liver cancer	0.000187	0.0015	CcSEcCtD
Etonogestrel—Anaphylactic shock—Doxorubicin—liver cancer	0.000187	0.0015	CcSEcCtD
Etonogestrel—Infection—Doxorubicin—liver cancer	0.000186	0.00149	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000184	0.00147	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—liver cancer	0.000184	0.00147	CcSEcCtD
Etonogestrel—Insomnia—Epirubicin—liver cancer	0.000183	0.00146	CcSEcCtD
Etonogestrel—Skin disorder—Doxorubicin—liver cancer	0.000182	0.00145	CcSEcCtD
Etonogestrel—Paraesthesia—Epirubicin—liver cancer	0.000182	0.00145	CcSEcCtD
Etonogestrel—Somnolence—Epirubicin—liver cancer	0.00018	0.00144	CcSEcCtD
Etonogestrel—Anorexia—Doxorubicin—liver cancer	0.000178	0.00143	CcSEcCtD
Etonogestrel—Dyspepsia—Epirubicin—liver cancer	0.000178	0.00142	CcSEcCtD
Etonogestrel—Decreased appetite—Epirubicin—liver cancer	0.000176	0.00141	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Epirubicin—liver cancer	0.000175	0.0014	CcSEcCtD
Etonogestrel—Fatigue—Epirubicin—liver cancer	0.000174	0.0014	CcSEcCtD
Etonogestrel—Pain—Epirubicin—liver cancer	0.000173	0.00138	CcSEcCtD
Etonogestrel—Constipation—Epirubicin—liver cancer	0.000173	0.00138	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000171	0.00136	CcSEcCtD
Etonogestrel—Insomnia—Doxorubicin—liver cancer	0.000169	0.00135	CcSEcCtD
Etonogestrel—Paraesthesia—Doxorubicin—liver cancer	0.000168	0.00134	CcSEcCtD
Etonogestrel—Feeling abnormal—Epirubicin—liver cancer	0.000167	0.00133	CcSEcCtD
Etonogestrel—Somnolence—Doxorubicin—liver cancer	0.000166	0.00133	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Epirubicin—liver cancer	0.000165	0.00132	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—liver cancer	0.000165	0.00132	CcSEcCtD
Etonogestrel—Decreased appetite—Doxorubicin—liver cancer	0.000163	0.0013	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000162	0.00129	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—liver cancer	0.000161	0.00129	CcSEcCtD
Etonogestrel—Urticaria—Epirubicin—liver cancer	0.000161	0.00129	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—liver cancer	0.00016	0.00128	CcSEcCtD
Etonogestrel—Pain—Doxorubicin—liver cancer	0.00016	0.00128	CcSEcCtD
Etonogestrel—Abdominal pain—Epirubicin—liver cancer	0.00016	0.00128	CcSEcCtD
Etonogestrel—Body temperature increased—Epirubicin—liver cancer	0.00016	0.00128	CcSEcCtD
Etonogestrel—Feeling abnormal—Doxorubicin—liver cancer	0.000154	0.00123	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Doxorubicin—liver cancer	0.000153	0.00122	CcSEcCtD
Etonogestrel—Hypersensitivity—Epirubicin—liver cancer	0.000149	0.00119	CcSEcCtD
Etonogestrel—Urticaria—Doxorubicin—liver cancer	0.000149	0.00119	CcSEcCtD
Etonogestrel—Abdominal pain—Doxorubicin—liver cancer	0.000148	0.00118	CcSEcCtD
Etonogestrel—Body temperature increased—Doxorubicin—liver cancer	0.000148	0.00118	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—MAPK8—liver cancer	0.000147	0.00156	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.000146	0.00155	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—CDKN1A—liver cancer	0.000145	0.00155	CbGpPWpGaD
Etonogestrel—Asthenia—Epirubicin—liver cancer	0.000145	0.00116	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000145	0.00154	CbGpPWpGaD
Etonogestrel—Pruritus—Epirubicin—liver cancer	0.000143	0.00114	CcSEcCtD
Etonogestrel—PGR—Gene Expression—NR1H4—liver cancer	0.000142	0.00152	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—liver cancer	0.000141	0.00151	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.000141	0.0015	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NR1I3—liver cancer	0.00014	0.00149	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—liver cancer	0.00014	0.00149	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000139	0.00148	CbGpPWpGaD
Etonogestrel—Diarrhoea—Epirubicin—liver cancer	0.000138	0.00111	CcSEcCtD
Etonogestrel—Hypersensitivity—Doxorubicin—liver cancer	0.000138	0.0011	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—liver cancer	0.000135	0.00143	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—TGFB1—liver cancer	0.000134	0.00143	CbGpPWpGaD
Etonogestrel—Asthenia—Doxorubicin—liver cancer	0.000134	0.00107	CcSEcCtD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000134	0.00143	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—STAT3—liver cancer	0.000134	0.00143	CbGpPWpGaD
Etonogestrel—Dizziness—Epirubicin—liver cancer	0.000134	0.00107	CcSEcCtD
Etonogestrel—Pruritus—Doxorubicin—liver cancer	0.000132	0.00106	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000132	0.0014	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—liver cancer	0.000132	0.0014	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TGFB1—liver cancer	0.000131	0.0014	CbGpPWpGaD
Etonogestrel—Vomiting—Epirubicin—liver cancer	0.000129	0.00103	CcSEcCtD
Etonogestrel—Diarrhoea—Doxorubicin—liver cancer	0.000128	0.00102	CcSEcCtD
Etonogestrel—Rash—Epirubicin—liver cancer	0.000128	0.00102	CcSEcCtD
Etonogestrel—Dermatitis—Epirubicin—liver cancer	0.000127	0.00102	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000127	0.00135	CbGpPWpGaD
Etonogestrel—Headache—Epirubicin—liver cancer	0.000127	0.00101	CcSEcCtD
Etonogestrel—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000124	0.00132	CbGpPWpGaD
Etonogestrel—Dizziness—Doxorubicin—liver cancer	0.000124	0.00099	CcSEcCtD
Etonogestrel—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000122	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.000122	0.00129	CbGpPWpGaD
Etonogestrel—Nausea—Epirubicin—liver cancer	0.00012	0.000961	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.00012	0.00128	CbGpPWpGaD
Etonogestrel—Vomiting—Doxorubicin—liver cancer	0.000119	0.000952	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.000119	0.00127	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—HNF4A—liver cancer	0.000118	0.00126	CbGpPWpGaD
Etonogestrel—Rash—Doxorubicin—liver cancer	0.000118	0.000944	CcSEcCtD
Etonogestrel—Dermatitis—Doxorubicin—liver cancer	0.000118	0.000943	CcSEcCtD
Etonogestrel—Headache—Doxorubicin—liver cancer	0.000117	0.000938	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000117	0.00125	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000116	0.00123	CbGpPWpGaD
Etonogestrel—Testosterone—ALB—liver cancer	0.000114	0.0173	CrCbGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—IL6—liver cancer	0.000113	0.00121	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CD—liver cancer	0.000113	0.0012	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000113	0.0012	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—KRAS—liver cancer	0.000111	0.00119	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000111	0.00119	CbGpPWpGaD
Etonogestrel—Nausea—Doxorubicin—liver cancer	0.000111	0.000889	CcSEcCtD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000111	0.00118	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.00011	0.00117	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CHN2—liver cancer	0.000109	0.00117	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000109	0.00116	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—liver cancer	0.000108	0.00115	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000107	0.00114	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—PPARA—liver cancer	0.000106	0.00113	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—EXOSC2—liver cancer	0.000105	0.00112	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000105	0.00112	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SHC3—liver cancer	0.000105	0.00111	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000104	0.0011	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—PIK3CA—liver cancer	0.000102	0.00109	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000102	0.00109	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—RAF1—liver cancer	0.000101	0.00108	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IFT88—liver cancer	0.0001	0.00107	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MTOR—liver cancer	9.91e-05	0.00106	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL6—liver cancer	9.89e-05	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MTOR—liver cancer	9.86e-05	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CB—liver cancer	9.86e-05	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—HRAS—liver cancer	9.78e-05	0.00104	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HNF4A—liver cancer	9.71e-05	0.00103	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—ESR1—liver cancer	9.6e-05	0.00102	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—HRAS—liver cancer	9.47e-05	0.00101	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—AKT1—liver cancer	9.34e-05	0.000995	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CDKN1B—liver cancer	9.25e-05	0.000985	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	9.13e-05	0.000972	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CASP3—liver cancer	9.11e-05	0.00097	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—IL6—liver cancer	9.07e-05	0.000965	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—liver cancer	8.87e-05	0.000945	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—JUN—liver cancer	8.85e-05	0.000943	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	8.79e-05	0.000935	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—PPARG—liver cancer	8.75e-05	0.000932	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	8.69e-05	0.000925	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—AKT1—liver cancer	8.64e-05	0.00092	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CDKN1A—liver cancer	8.54e-05	0.000909	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PSMA4—liver cancer	8.48e-05	0.000903	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PSMD10—liver cancer	8.48e-05	0.000903	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	8.41e-05	0.000896	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—AKT1—liver cancer	8.36e-05	0.000891	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR1H4—liver cancer	8.36e-05	0.00089	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—HPGDS—liver cancer	8.28e-05	0.000882	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR1I3—liver cancer	8.22e-05	0.000875	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	8.12e-05	0.000865	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FST—liver cancer	8.12e-05	0.000864	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—SERPINE1—liver cancer	7.89e-05	0.00084	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TRIO—liver cancer	7.74e-05	0.000824	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	7.73e-05	0.000824	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	7.71e-05	0.000821	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	7.55e-05	0.000804	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCR4—liver cancer	7.42e-05	0.00079	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	7.35e-05	0.000783	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	7.34e-05	0.000781	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	7.28e-05	0.000775	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—liver cancer	7.12e-05	0.000758	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	7.11e-05	0.000757	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	6.94e-05	0.000739	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP2E1—liver cancer	6.75e-05	0.000719	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	6.66e-05	0.000709	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—liver cancer	6.58e-05	0.0007	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—liver cancer	6.54e-05	0.000696	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	6.41e-05	0.000682	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARA—liver cancer	6.22e-05	0.000662	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GGT1—liver cancer	6.2e-05	0.00066	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SHC3—liver cancer	6.13e-05	0.000653	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—liver cancer	6.01e-05	0.00064	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.9e-05	0.000628	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.88e-05	0.000626	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADAM17—liver cancer	5.87e-05	0.000625	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—liver cancer	5.84e-05	0.000622	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—H2AFX—liver cancer	5.73e-05	0.00061	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HNF4A—liver cancer	5.7e-05	0.000607	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTP1—liver cancer	5.57e-05	0.000593	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—liver cancer	5.56e-05	0.000592	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PSMA4—liver cancer	5.52e-05	0.000587	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PSMD10—liver cancer	5.52e-05	0.000587	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	5.49e-05	0.000585	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	5.49e-05	0.000585	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	5.45e-05	0.00058	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—liver cancer	5.32e-05	0.000567	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARG—liver cancer	5.14e-05	0.000547	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—liver cancer	5.12e-05	0.000545	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARA—liver cancer	5.1e-05	0.000543	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.05e-05	0.000537	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	5.01e-05	0.000533	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—liver cancer	4.99e-05	0.000531	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PSMD10—liver cancer	4.98e-05	0.00053	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PSMA4—liver cancer	4.98e-05	0.00053	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—liver cancer	4.94e-05	0.000525	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—liver cancer	4.91e-05	0.000523	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1A1—liver cancer	4.85e-05	0.000516	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.84e-05	0.000516	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	4.78e-05	0.000509	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FST—liver cancer	4.76e-05	0.000507	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MAPK14—liver cancer	4.71e-05	0.000501	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—SERPINE1—liver cancer	4.63e-05	0.000493	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ESR1—liver cancer	4.62e-05	0.000492	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TRIO—liver cancer	4.54e-05	0.000484	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCR4—liver cancer	4.36e-05	0.000464	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PRKCE—liver cancer	4.27e-05	0.000455	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARG—liver cancer	4.21e-05	0.000449	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	4.09e-05	0.000435	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF2—liver cancer	4.05e-05	0.000431	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SERPINE1—liver cancer	3.8e-05	0.000404	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CSF2—liver cancer	3.78e-05	0.000403	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—H2AFX—liver cancer	3.73e-05	0.000397	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—UGDH—liver cancer	3.63e-05	0.000386	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADAM17—liver cancer	3.44e-05	0.000367	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—EPT1—liver cancer	3.41e-05	0.000363	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TERT—liver cancer	3.37e-05	0.000359	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—H2AFX—liver cancer	3.36e-05	0.000358	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PSMD10—liver cancer	3.24e-05	0.000345	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PSMA4—liver cancer	3.24e-05	0.000345	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TAT—liver cancer	3.23e-05	0.000344	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KDR—liver cancer	3.08e-05	0.000328	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK14—liver cancer	3.06e-05	0.000326	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ESR1—liver cancer	3e-05	0.00032	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARA—liver cancer	2.99e-05	0.000319	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—F2—liver cancer	2.97e-05	0.000316	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—liver cancer	2.93e-05	0.000312	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CG—liver cancer	2.84e-05	0.000302	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APC—liver cancer	2.84e-05	0.000302	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MAPK14—liver cancer	2.76e-05	0.000294	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BRAF—liver cancer	2.67e-05	0.000284	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PRKCE—liver cancer	2.51e-05	0.000267	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CD—liver cancer	2.5e-05	0.000266	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARG—liver cancer	2.47e-05	0.000263	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SERPINE1—liver cancer	2.47e-05	0.000263	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—liver cancer	2.4e-05	0.000256	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF2—liver cancer	2.38e-05	0.000253	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SERPINE1—liver cancer	2.23e-05	0.000237	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RAF1—liver cancer	2.23e-05	0.000237	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CSF2—liver cancer	2.22e-05	0.000236	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GLUL—liver cancer	2.2e-05	0.000234	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CPT1B—liver cancer	2.2e-05	0.000234	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—H2AFX—liver cancer	2.19e-05	0.000233	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MTOR—liver cancer	2.18e-05	0.000232	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CB—liver cancer	2.18e-05	0.000232	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NR1H4—liver cancer	2.12e-05	0.000226	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTA3—liver cancer	2.08e-05	0.000222	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1B—liver cancer	2.04e-05	0.000217	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASP3—liver cancer	2e-05	0.000213	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—liver cancer	2e-05	0.000213	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TERT—liver cancer	1.98e-05	0.000211	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—liver cancer	1.95e-05	0.000207	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JUN—liver cancer	1.94e-05	0.000207	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNB1—liver cancer	1.93e-05	0.000205	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTA4—liver cancer	1.91e-05	0.000203	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—liver cancer	1.89e-05	0.000201	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1A—liver cancer	1.88e-05	0.000201	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTA2—liver cancer	1.86e-05	0.000198	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MAPK8—liver cancer	1.84e-05	0.000196	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KDR—liver cancer	1.81e-05	0.000193	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK14—liver cancer	1.8e-05	0.000191	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTA1—liver cancer	1.79e-05	0.000191	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NAT2—liver cancer	1.77e-05	0.000189	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—F2—liver cancer	1.74e-05	0.000185	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALDOB—liver cancer	1.7e-05	0.000181	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—liver cancer	1.7e-05	0.000181	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—STAT3—liver cancer	1.68e-05	0.000179	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CG—liver cancer	1.67e-05	0.000177	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APC—liver cancer	1.67e-05	0.000177	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—liver cancer	1.67e-05	0.000177	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CRABP1—liver cancer	1.62e-05	0.000173	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BRAF—liver cancer	1.57e-05	0.000167	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—liver cancer	1.56e-05	0.000166	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFB1—liver cancer	1.56e-05	0.000166	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CD—liver cancer	1.46e-05	0.000156	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SERPINE1—liver cancer	1.45e-05	0.000154	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—liver cancer	1.44e-05	0.000154	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HPGDS—liver cancer	1.42e-05	0.000151	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—liver cancer	1.41e-05	0.00015	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—liver cancer	1.33e-05	0.000141	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RAF1—liver cancer	1.31e-05	0.000139	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—liver cancer	1.28e-05	0.000137	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CB—liver cancer	1.28e-05	0.000136	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MTOR—liver cancer	1.28e-05	0.000136	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PSMD10—liver cancer	1.26e-05	0.000134	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PSMA4—liver cancer	1.26e-05	0.000134	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GOT2—liver cancer	1.23e-05	0.000131	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—liver cancer	1.23e-05	0.000131	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1B—liver cancer	1.2e-05	0.000128	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP3—liver cancer	1.17e-05	0.000125	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—liver cancer	1.17e-05	0.000125	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—liver cancer	1.17e-05	0.000125	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2E1—liver cancer	1.15e-05	0.000123	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—liver cancer	1.14e-05	0.000122	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JUN—liver cancer	1.14e-05	0.000121	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNB1—liver cancer	1.13e-05	0.000121	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—liver cancer	1.11e-05	0.000118	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1A—liver cancer	1.11e-05	0.000118	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—liver cancer	1.08e-05	0.000115	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYCS—liver cancer	1.08e-05	0.000115	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MAPK8—liver cancer	1.08e-05	0.000115	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GGT1—liver cancer	1.06e-05	0.000113	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GOT1—liver cancer	1.06e-05	0.000113	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—liver cancer	9.97e-06	0.000106	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—STAT3—liver cancer	9.87e-06	0.000105	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—liver cancer	9.78e-06	0.000104	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTP1—liver cancer	9.52e-06	0.000101	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMOX1—liver cancer	9.39e-06	0.0001	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—liver cancer	9.17e-06	9.76e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFB1—liver cancer	9.15e-06	9.74e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—liver cancer	8.75e-06	9.32e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—liver cancer	8.47e-06	9.02e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1A1—liver cancer	8.29e-06	8.83e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—liver cancer	7.78e-06	8.29e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—liver cancer	7.73e-06	8.23e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARA—liver cancer	7.59e-06	8.08e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—liver cancer	7.53e-06	8.02e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—liver cancer	7.2e-06	7.67e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—liver cancer	6.89e-06	7.34e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CG—liver cancer	6.5e-06	6.92e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—liver cancer	6.36e-06	6.77e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARG—liver cancer	6.27e-06	6.68e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CD—liver cancer	5.71e-06	6.08e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALB—liver cancer	5.64e-06	6e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CB—liver cancer	4.98e-06	5.3e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—liver cancer	3.03e-06	3.23e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—liver cancer	2.48e-06	2.64e-05	CbGpPWpGaD
